Pfizer's dividend payout ratio is high, but the company is generated enough free cash flow to cover its dividend. Management remains committed to the dividend program despite Pfizer facing a patent ...

Pfizer Inc. is undervalued at 8-9× forward earnings, offering a nearly 7% dividend yield and significant upside potential. Recent acquisitions, especially Seagen, position PFE for robust growth, with ...

How many profitable, large-cap healthcare companies pay a dividend yield of over 5%? Only one. Pfizer (NYSE: PFE) checks off all the boxes. It's profitable, raking in earnings of over $9.4 billion in ...

One reason why many investors could be asking this question is Pfizer's high dividend payout ratio of 99.4%. This metric represents a company's dividend per share divided by its earnings per share.